141 related articles for article (PubMed ID: 8372818)
1. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyurea.
Hwang WL; Gau JP; Chen MC; Young JH
Am J Hematol; 1993 Aug; 43(4):323-4. PubMed ID: 8372818
[No Abstract] [Full Text] [Related]
2. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
3. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
[TBL] [Abstract][Full Text] [Related]
4. The "retinoic acid syndrome" in acute promyelocytic leukemia.
Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
Vosburgh E
Leukemia; 1992 Jun; 6(6):608-10. PubMed ID: 1602800
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
Limentani SA; Pretell JO; Potter D; DuBois JS; Daoust PR; Spieler PS; Miller KB
Am J Hematol; 1994 Sep; 47(1):50-5. PubMed ID: 8042616
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia.
Mamez AC; Raffoux E; Chevret S; Lemiale V; Boissel N; Canet E; Schlemmer B; Dombret H; Azoulay E; Lengliné E
Leuk Lymphoma; 2016 Oct; 57(10):2281-8. PubMed ID: 26849624
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of therapeutic leukapheresis in acute promyelocytic leukemia: A single-center retrospective cohort study.
Lee H; Yoon JH; Cho BS; Kim HJ; Jekarl DW; Kim Y
Cytotherapy; 2023 Jun; 25(6):659-669. PubMed ID: 36774295
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid syndrome in acute promyelocytic leukemia.
Sentero D; Hosenpud J
Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
[TBL] [Abstract][Full Text] [Related]
11. Case report: all-trans retinoic acid, hyperleukocytosis, and marrow infarction.
Lopez P; Hayne O
Am J Hematol; 1992 Dec; 41(4):305-6. PubMed ID: 1288302
[No Abstract] [Full Text] [Related]
12. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
[TBL] [Abstract][Full Text] [Related]
13. [All-trans retinoic acid for thromboembolic events in patients with M3 leukemia: a case report].
Yin F; Zheng WY; Meng FY; Jiang ZJ; Liu XL; Feng R; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):187-8. PubMed ID: 12581981
[TBL] [Abstract][Full Text] [Related]
14. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
15. [Retinoic acid in treating acute promyelocytic leukemia with hyperleukocytosis and its therapeutic strategy].
Guo XH; Yasen H; Jiang M; Hao JP; Abulaiti D; Chen R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):439-41. PubMed ID: 18426682
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.
Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR
Leukemia; 1994 Jun; 8(6):929-33. PubMed ID: 8207986
[TBL] [Abstract][Full Text] [Related]
17. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
[TBL] [Abstract][Full Text] [Related]
18. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Yang J; Han Z; Pei M; Xiao N
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
[TBL] [Abstract][Full Text] [Related]
19. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
Macaron W; Sargsyan Z; Short NJ
Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute promyelocytic leukemia with all-trans retinoic acid.
Fenaux P; Degos L
Leuk Res; 1991; 15(8):655-7. PubMed ID: 1895747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
